Symons Julian A. has filed 13 insider transactions across 1 company since March 2023.
Most recent transaction: a grant/award of 23310 shares of Aligos Therapeutics, Inc. ($ALGS) on March 09, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 9, 2026 | Aligos Therapeutics, Inc. | $ALGS | Symons Julian A. | See Remarks | A | Stock Option (Right to Buy) | 23310 | $0.00 | 23,310.0000 | 6,153,507 | 9999.99% | 0.38% |
| July 16, 2025 | Aligos Therapeutics, Inc. | $ALGS | Symons Julian A. | See Remarks | A | Stock Option (Right to Buy) | 16000 | $0.00 | 16,000.0000 | 3,864,436 | 9999.99% | 0.41% |
| Feb. 28, 2025 | Aligos Therapeutics, Inc. | $ALGS | Symons Julian A. | See Remarks | A | Stock Option (Right to Buy) | 21693 | $0.00 | 21,693.0000 | 3,864,436 | 9999.99% | 0.56% |
| Sept. 4, 2024 | Aligos Therapeutics, Inc. | $ALGS | Symons Julian A. | See Remarks | A | Stock Option (Right to Buy) | 10880 | $0.00 | 10,880.0000 | 79,900,000 | 9999.99% | 0.01% |
| March 1, 2024 | Aligos Therapeutics, Inc. | $ALGS | Symons Julian A. | See Remarks | A | Stock Option (Right to Buy) | 72000 | $0.00 | 72,000.0000 | 3,003,855 | 9999.99% | 2.40% |
| Feb. 27, 2024 | Aligos Therapeutics, Inc. | $ALGS | Symons Julian A. | See Remarks | D | Stock Option (Right to Buy) | 105000 | $0.00 | 0.0000 | 3,003,855 | 100.00% | 3.50% |
| Feb. 27, 2024 | Aligos Therapeutics, Inc. | $ALGS | Symons Julian A. | See Remarks | D | Stock Option (Right to Buy) | 26250 | $0.00 | 0.0000 | 3,003,855 | 100.00% | 0.87% |
| Feb. 28, 2024 | Aligos Therapeutics, Inc. | $ALGS | Symons Julian A. | See Remarks | A | Stock Option (Right to Buy) | 58822 | $0.00 | 58,822.0000 | 3,003,855 | 9999.99% | 1.96% |
| Feb. 27, 2024 | Aligos Therapeutics, Inc. | $ALGS | Symons Julian A. | See Remarks | D | Stock Option (Right to Buy) | 200000 | $0.00 | 0.0000 | 3,003,855 | 100.00% | 6.66% |
| Feb. 28, 2024 | Aligos Therapeutics, Inc. | $ALGS | Symons Julian A. | See Remarks | A | Stock Option (Right to Buy) | 18750 | $0.00 | 18,750.0000 | 3,003,855 | 9999.99% | 0.62% |
| Feb. 28, 2024 | Aligos Therapeutics, Inc. | $ALGS | Symons Julian A. | See Remarks | A | Stock Option (Right to Buy) | 74998 | $0.00 | 74,998.0000 | 3,003,855 | 9999.99% | 2.50% |
| Sept. 8, 2023 | Aligos Therapeutics, Inc. | $ALGS | Symons Julian A. | See Remarks | A | Stock Option (Right to Buy) | 48000 | $0.00 | 48,000.0000 | 0 | 9999.99% | 0.00% |
| March 15, 2023 | Aligos Therapeutics, Inc. | $ALGS | Symons Julian A. | See Remarks | A | Stock Option (Right to Buy) | 78750 | $0.00 | 78,750.0000 | 0 | 9999.99% | 0.00% |